|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0026764,
umls-concept:C0079611,
umls-concept:C0220825,
umls-concept:C0229671,
umls-concept:C0430292,
umls-concept:C0806492,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707455,
umls-concept:C2911692
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-4-20
|
|
pubmed:abstractText |
To investigate the impact of immunophenotypic response (IR) versus complete response (CR) and CR plus normal serum free light chain (sFLC) ratio (stringent CR) in elderly patients with multiple myeloma (MM) treated with novel agents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AlonsoLourdesL,
pubmed-author:BengoecheaEnriqueE,
pubmed-author:BladéJoanJ,
pubmed-author:Fernandez-RedondoElenaE,
pubmed-author:LahuertaJuan-JoseJJ,
pubmed-author:LarañaJosé-GarciaJG,
pubmed-author:MartinAlejandroA,
pubmed-author:Martinez-LopezJoaquinJ,
pubmed-author:MateosMaria-VictoriaMV,
pubmed-author:MediavillaJoaquin DiazJD,
pubmed-author:MontalbanMaria-AngelesMA,
pubmed-author:OrfaoAlbertoA,
pubmed-author:OriolAlbertA,
pubmed-author:PaivaBrunoB,
pubmed-author:PalomeraLuisL,
pubmed-author:San MiguelJesus FJF,
pubmed-author:TeruelAna-IsabelAI,
pubmed-author:VidrialesMaria-BelenMB,
pubmed-author:de ArribaFelipeF,
pubmed-author:de PazRaquelR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1627-33
|
|
pubmed:meshHeading |
pubmed-meshheading:21402611-Aged,
pubmed-meshheading:21402611-Aged, 80 and over,
pubmed-meshheading:21402611-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21402611-Disease-Free Survival,
pubmed-meshheading:21402611-Female,
pubmed-meshheading:21402611-Flow Cytometry,
pubmed-meshheading:21402611-Fluorescent Antibody Technique,
pubmed-meshheading:21402611-Humans,
pubmed-meshheading:21402611-Immunoglobulin Light Chains,
pubmed-meshheading:21402611-Immunologic Techniques,
pubmed-meshheading:21402611-Immunophenotyping,
pubmed-meshheading:21402611-Kaplan-Meier Estimate,
pubmed-meshheading:21402611-Male,
pubmed-meshheading:21402611-Multiple Myeloma,
pubmed-meshheading:21402611-Nephelometry and Turbidimetry,
pubmed-meshheading:21402611-Predictive Value of Tests,
pubmed-meshheading:21402611-Proportional Hazards Models,
pubmed-meshheading:21402611-Prospective Studies,
pubmed-meshheading:21402611-Risk Assessment,
pubmed-meshheading:21402611-Risk Factors,
pubmed-meshheading:21402611-Spain,
pubmed-meshheading:21402611-Survival Rate,
pubmed-meshheading:21402611-Time Factors,
pubmed-meshheading:21402611-Treatment Outcome,
pubmed-meshheading:21402611-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma.
|
|
pubmed:affiliation |
Hospital Universitario de Salamanca, Salamanca, Spain.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
